Diebold Nixdorf, Incorporated
NYSE:DBDSoftware - Application
+$1.71 today
- Market cap
- $1.77B
- Beta
- 1.13
- P/E (TTM)
- 26.9
- EPS (TTM)
- $3.07
Volume 0.42M
Average 0.43M
DBD Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Diebold Nixdorf, IncorporatedNYSE: DBD
Other Non-Cash Items · Q2 FY2026 · quarter ended Jun 2026
Other non-cash items turns negative
Q2 FY2026 other non-cash items was -$77.9M, compared with $27.1M a year earlier. Trailing-twelve-month other non-cash items was -$70.3M. Over 3 fiscal years it compounded at -23.4% a year.
Context
- Other non-cash items amounted to 1.6% of revenue in FY2025, up 1.1 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly other non-cash items holds near -$77.9M or moves back toward the trailing-twelve-month quarterly average of -$17.58M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 60.9M USD
- Year-over-year change
- +254.1%
- 4-year CAGR
- +13.9%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 60.9M | +254.1% |
| FY2024 | 2024-12-31 | 17.2M | +101.1% |
| FY2023 | 2023-12-31 | (1.62B) | -1299.0% |
| FY2022 | 2022-12-31 | 135.4M | +274.0% |
| FY2021 | 2021-12-31 | 36.2M | — |
Other Non-Cash Items vs competitors
How DBD compares with its peers on the latest reported figures
- DBD's LTM Jun 2026 other non-cash items of $70.3M is the 4th largest of the 10 companies compared; the peer median is $3.55M.
- Its year-over-year change of -2.0% is the 6th highest of 9, against a peer median of +127.2%.
- Other non-cash items amounts to 1.8% of revenue for DBD, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
WBTNWEBTOON Entertainment Inc. Common stock | LTM Mar 2026 | $377.79M | +380.3% | +121.6% | 27.4% |
| LTM Sep 2026 | $77.48M | +261.8% | +15.7% | 7.1% | |
| LTM Sep 2026 | $73.22M | -1711.4% | — | 4.0% | |
| LTM Jun 2026 | $70.3M | -2.0% | -23.4% | 1.8% | |
| LTM Feb 2026 | $22.26M | +35.8% | — | 2.3% | |
| LTM Sep 2026 | $12.77M | +235.8% | — | 1.5% | |
| LTM Jun 2026 | $5.22M | — | — | 3.8% | |
| LTM Mar 2026 | $3.55M | +218.7% | -54.8% | 0.8% | |
| LTM Apr 2026 | $2.3M | -61.1% | — | 0.3% | |
| LTM Jun 2026 | $54K | -100.1% | +22.4% | 0.0% | |
| Peer median (excluding DBD) | $3.55M | +127.2% | +19.1% | 2.3% | |
Competitors are the stored peer set for DBD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (78.8M) | (585.6M) | 1.38B | (14.5M) | 94.6M |
| Depreciation & Amortization | 149.1M | 126M | 136.3M | 132.3M | 127.5M |
| Deferred Income Tax | (12.6M) | 92.9M | 36.6M | (34.1M) | (48.1M) |
| Stock-Based Compensation | 0 | 13.4M | 0 | 9.7M | 0 |
| Change in Working Capital | 29.4M | (170M) | (182.5M) | 38.6M | 65.8M |
| Accounts Receivables | 16.4M | (49.4M) | (91.7M) | 99.6M | 25.9M |
| Inventory | (84.8M) | (74.5M) | 52.7M | 20.9M | 65.1M |
| Accounts Payables | 241.4M | (66.5M) | (65.4M) | (42.2M) | (68.3M) |
| Other Working Capital | (143.6M) | 20.4M | (78.1M) | (39.7M) | 43.1M |
| Other Non-Cash Items | 36.2M | 135.4M | (1.62B) | 17.2M | 60.9M |
| Operating Cash Flow | 123.3M | (387.9M) | (257M) | 149.2M | 300.7M |
| Capital Expenditures | (51.3M) | (53.1M) | (24.9M) | (17.4M) | (37.4M) |
| Acquisitions (Net) | 15.5M | 10.5M | 0 | 0 | (24.5M) |
| Purchases of Investments | (288.4M) | (401.3M) | (270.5M) | (295.2M) | (318.4M) |
| Sales of Investments | 287.7M | 414.1M | 282.2M | 288.8M | 306M |
| Other Investing Activities | 0 | 6M | 0 | (21.7M) | 1M |
| Investing Cash Flow | (36.5M) | (23.8M) | (36.1M) | (45.5M) | (97.6M) |
| Debt Repayment | (7.3M) | 376.1M | 565.2M | (300.1M) | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (130.7M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9M) | (26.3M) | (5.7M) | (66.4M) | (13.2M) |
| Financing Cash Flow | (16.3M) | 349.8M | 559.5M | (366.5M) | (143.9M) |
| Effect of Forex Changes | (6.1M) | (8.2M) | 6.8M | (18.2M) | 16.8M |
| Net Change in Cash | 64.4M | (69.8M) | 273.2M | (281M) | 76M |
| Free Cash Flow | 72M | (441M) | (281.9M) | 131.8M | 263.3M |
Diebold Nixdorf, Incorporated
NYSE:DBD
Intrinsic Alpha fair value
Locked
Current Price
$52.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.